US20120108820A1 - Ionic liquids based on imidazolium salts incorporating a nitrile functionality - Google Patents

Ionic liquids based on imidazolium salts incorporating a nitrile functionality Download PDF

Info

Publication number
US20120108820A1
US20120108820A1 US13/328,353 US201113328353A US2012108820A1 US 20120108820 A1 US20120108820 A1 US 20120108820A1 US 201113328353 A US201113328353 A US 201113328353A US 2012108820 A1 US2012108820 A1 US 2012108820A1
Authority
US
United States
Prior art keywords
nmr
synthesis
ionic liquids
yield
acetone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/328,353
Inventor
Paul Dyson
Dongbin Zhao
Zhaofu Fei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US13/328,353 priority Critical patent/US20120108820A1/en
Publication of US20120108820A1 publication Critical patent/US20120108820A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0215—Sulfur-containing compounds
    • B01J31/0218—Sulfides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0277—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature
    • B01J31/0278—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre
    • B01J31/0281—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre the nitrogen being a ring member
    • B01J31/0284—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre the nitrogen being a ring member of an aromatic ring, e.g. pyridinium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0277—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature
    • B01J31/0278—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre
    • B01J31/0285—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre also containing elements or functional groups covered by B01J31/0201 - B01J31/0274
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/26—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24
    • B01J31/28—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24 of the platinum group metals, iron group metals or copper
    • B01J31/30—Halides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/40—Regeneration or reactivation
    • B01J31/4015—Regeneration or reactivation of catalysts containing metals
    • B01J31/4023—Regeneration or reactivation of catalysts containing metals containing iron group metals, noble metals or copper
    • B01J31/4038—Regeneration or reactivation of catalysts containing metals containing iron group metals, noble metals or copper containing noble metals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • B01J2231/4211—Suzuki-type, i.e. RY + R'B(OR)2, in which R, R' are optionally substituted alkyl, alkenyl, aryl, acyl and Y is the leaving group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/821—Ruthenium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/824—Palladium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/828—Platinum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/584—Recycling of catalysts

Definitions

  • ionic liquids in synthesis and catalysis are attractive features of ionic liquids in synthesis and catalysis, so that a liquid can be tailored to specific applications.
  • task-specific ionic liquids has been used to describe low melting salts with functional groups, such as amine and amide, sulfonic acid, ether and alcohol, carboxylic, urea and thiourea and phosphine functionalities, as well as fluorous chains attached to the alkyl side chains.
  • hetero atoms must be a quaternized nitrogen atom having a —R′CN substituent, wherein R′ is alkyl (C 1 to C 12 );
  • imidazolium and pyridinium rings are particularly preferred. Essentially any combination of cation with one or more R′C ⁇ N groups with any anion that results in a salt with a melting point below 100° C. is included.
  • the salts are washed with water in order to remove the hydrogen chloride formed during the anion exchange reaction, whereas tetrohydrofuran and diethyl ether are used to wash 1c-5c.
  • the salts are then dried under vacuum for 1-2 days.
  • the salts 2c, 3c, 4a, 4b and 3c are liquid at room temperature and are further purified by filtration through silica and left under vacuum at 40-50° C. for several days. All the imidazolium salts are obtained in medium to high yield. They are stable in air and show no signs of decomposition up to 150° C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Lubricants (AREA)

Abstract

Novel chemical compounds of the general formula

K+A−
useful as industrial solvents, especially as ligands, for efficient catalyst recycling.

Description

    FIELD OF THE INVENTION
  • This invention relates to novel ionic liquids. The ionic liquids can be used as solvents to immobilize catalysts for the biphasic or multiphasic synthesis of chemical products such as pharmaceuticals.
    • BACKGROUND OF THE INVENTION
  • Ionic liquids are salts with a melting temperature below the boiling point of water. Ionic liquids useful as solvents in industrial applications are also liquids at room temperature.
  • Room temperature ionic liquids or molten salts were described for the first time in U.S. Pat. No. 2,446,331. The problem with these ionic liquids described in this patent is that the anionic component can decompose on contact with atmospheric moisture.
  • More recently, air and moisture stable ionic liquids have been prepared, and now extensive studies have been carried out in two main areas:
  • 1. The development of new ionic liquids based on many different cation and anion combinations.
  • 2. The application of ionic liquids as immobilizing media for lanthanide and actinide series and transition metal catalysts.
  • Ionic liquids are currently attracting considerable attention as novel solvents for organic synthesis and catalysis because the chemical industry is under pressure to replace environmentally damaging volatile organic solvents with more benign alternatives. “Room temperature ionic liquids”, especially those based on 1,3-dialkylimidazolium cations, have emerged as leading contenders since they have negligible vapor pressure, are air and moisture stable, and are highly solvating for both ionic and molecular species, and as a result are suitable for multiphasic catalysis. Although applications in synthesis and catalysis have been most widely explored, with the first industrial scale process now on-line for over a year, ionic liquids are also finding uses in separation processes, in electrochemistry, as electrolytes in solar cells, as lubricants, and as matrices in MALDI mass spectrometry.
  • One of the attractive features of ionic liquids in synthesis and catalysis is that both the cationic and anionic components can be varied and modified, so that a liquid can be tailored to specific applications. The term “task-specific ionic liquids” has been used to describe low melting salts with functional groups, such as amine and amide, sulfonic acid, ether and alcohol, carboxylic, urea and thiourea and phosphine functionalities, as well as fluorous chains attached to the alkyl side chains. The definition of task-specific ionic liquids is also extended to include ionic liquids with functional anions such as carboranes, metal carbonyl anions such as [Co(CO)4]−; the proprietary catalyst [Rh(CO)2|2]− and alkylselenites.
  • If ionic liquids are to be used to immobilize catalysts in multiphasic reactions, then the design and synthesis of task-specific ionic liquids is extremely important. Many different reactions have been catalyzed using ionic liquids as immobilization solvents including hydrogenation, hydroformylation and C—C coupling reactions. While the non-nucleophilic nature of many ionic liquids seems to be advantageous, providing a protective environment for the catalyst which can extend its lifetime, it has also emerged that ionic liquids that incorporate a coordination centre might be extremely useful, such that the ionic liquid serves as both immobilization solvent and ligand to the catalyst. Wasserscheid et a/first described this concept by introducing a diphenylphosphine group at the 2-position of an imidazolium cation; the resulting salt was a not a “room temperature ionic liquid” and had to be dissolved in another ionic liquid for effective use in biphasic catalysis. The ligand, by virtue of being a salt, is highly soluble in ionic liquids and is strongly retained during product extraction. Groups such as NH2 and OH have also been successfully introduced into the imidazolium cation moieties but their ability to coordinate to lanthanide and actinide series and transition metals to give catalytically useful complexes is somewhat limited. More sophisticated functional groups such as thioureas and thioethers have been tethered to imidazolium based ionic liquids and they have been shown to extract toxic metal ions from aqueous solution.
  • It is one object of this invention to provide the synthesis and characterization of quaternized nitrogen-containing heterocyclic compounds, e.g. especially imidazolium or pyridinium heterocyclic compounds, such as salts, in which a nitrile group is attached to the alkyl side chain. The nitrite group is chosen as it is a promising donor to main group metals such as lithium and potassium, as well as lanthanide and actinide series and transition metals such as palladium and platinum. The physicochemical properties of these new ionic liquids are described. It is a further object of this invention to provide information about the relationship of the length of the alkyl unit linking the quaternized nitrogen-containing heterocyclic ring and the CN group, and how this relationship influences the melting point of the ionic liquid. Yet another object of this invention is to produce ionic liquids, which provide coordination centers (i.e. that act as ligands), while maintaining a low melting point, less than about 100° C., ideally at or below room temperature (i.e., acting as a solvent). A still further object of the invention is to demonstrate the applicability of these new ionic liquids in catalysis; as they have particular value in the immobilization of catalysts, enabling the catalyst to be recovered and efficiently recycled.
  • It is yet a further aspect of the invention to provide dual-functionalized ionic liquids and their properties.
    • DESCRIPTION AND SUMMARY OF THE INVENTION
  • Novel chemical compounds are provided of the general formula,

  • K+A−,
  • in which K+ is a 5- or 6-membered heterocyclic ring having 1-3 hetero atoms, which can be independently N, S, or O;
  • with the proviso that at least one of the hetero atoms must be a quaternized nitrogen atom having a —R′CN substituent, wherein R′ is alkyl (C1 to C12);
  • the heterocyclic ring having up to 4 or 5 substituents independently chosen from the moieties:
      • (i) H;
      • (ii) halogen or
      • (iii) alkyl (C1 to C12), which is unsubstituted or partially or fully substituted by further groups, preferably F, Cl, N(CnF(2n+1−x)Hx)2, O(CnF(2n+1−x)Hx), SO2(CnF(2n+1−x)Hx)2 or CnF(2n+1−x)Hx where 1<n<6 and 0<x<13; and
      • (iv) a phenyl ring which is unsubstituted or partially or fully substituted by further groups, preferably F, Cl, N(CnF(2n+1−x)Hx)2, O(CnF(2n+1−x)Hx), SO2(CnF(2n+1−x)Hx)2 or CnF(2n+1−x)Hx where 1<n<6 and 0<x≦13; and
  • A− is any anion that provides a salt with a low melting point, below about 100° C. Most preferably, A is halide, such as chloride, bromide, fluoride and the like; BF4 −, PF5 −, NO3 −, CH3CO2 −, CF3SO3 −, (CF3SO2)2N−, (CF3SO2)3C−, CF3CO2 − or N(CN)2 −.
  • These compounds are useful in the immobilization of catalyst, especially lanthanide and actinide series and transition metal chlorides, such as palladium and platinum chlorides, to form complexes soluble in the ionic liquid. The catalysts can be recovered and recycled easily from the ionic liquids.
  • In the above compounds, the group R′C≡N where R′ is an alkyl acts as the functional group and must always be present. More than one R′C≡N group may also be included, either attached to nitrogen or a carbon in the ring.
  • Particularly preferred as the K+ ring are the pyrrolium, pyrazolium, pyridinium, pyrazinium, pyrimidinium, imidazolium, thiazolium, oxazolium, and triazolium rings, some of which are illustrated in the series depicted below,
  • Figure US20120108820A1-20120503-C00001
  • Most particularly preferred are the imidazolium and pyridinium rings. Essentially any combination of cation with one or more R′C≡N groups with any anion that results in a salt with a melting point below 100° C. is included.
  • In a further aspect the invention provides ionic liquids with a functionalized anion, in place of the usual anions which include BF4 −, PF6 −, NO3 −, CH3CO2 −, CF3SO3 −, (CF3SO2)2N−, (CF3SO2)3C−, CF3CO2 −, N(CN)2 −. The functionalized anion mya be a nitrile functionalized anion, e.g. [BF3RCN]− wherein R′ is alkyl (C1 to C18, for example C1 to C1 to C12). Preferably the anion is [BF3CHCH3CH2CN]−.
  • How to make the Ionic K+A− Liquids
  • The synthetic route to prepare the K+S− salts utilizes as starting material the appropriate alkyl-substituted heterocyclic compound, which is then reacted with the appropriate chloroalkyl nitrile. The reactants are employed in approximately equimolar quantities, in a solvent which can be any of the usual solvent systems for heterocyclic chemistry, such as tetrahydofuran, acetonitrile, and diethyl ether. The reaction proceeds at ambient temperatures up to about 200° C.
  • The synthesis of e.g., 1-alkylnitrile-3-methylimidazolium and 1-alkylnitrile-2,3-dimethylimidazolium salts is depicted in Scheme 1, below. The imidazolium chlorides, e.g., [1-alkylnitrile-3-methylimidazolium][Cl], wherein alkyl is C=1-12, especially C=1-4, such as (Cn=(CH2)n, n=1 1a, n=2 2a, n=3 3a and n=4 4a) are prepared in high yield from 1-methylimidazole and the appropriate chloroalkyl nitrile Cl(CH2)nCN in a modification to the literature procedure for the related 1-alkyl-3-methylimidazolium chlorides. The 1-alkylnitrile-2,3-dimethylimidazollum salt [1-alkylnitrile-3-methylimidazolium]Cl 5a is prepared similarly from 1,2-dimethylimidazole and Cl(CH2)3CN. The synthesis of 1a has been described previously using an alternative a somewhat more complicated method. Both methods are found in the references: (a) Hitchcock, P. B.; Seddon, K. R.; Welton, T. J. Chem. Soc. Dalton Trans. 1993, 2639. (b) Suarez, P. A. Z.; Dullius, J. E. L.; Einloft, S.; de Souza, R. F.; Dupont, J. Polyhedron 1996, 15, 1217, and Herrmann, W. A.; Goossen, L. J.; Spiegler, M.; Organometallics 1998, 17, 2162.
  • The relatively strong electron withdrawing effect of the nitrite group activates chloromethylacetonitrile ClCH2CN to such an extent that it reacts smoothly with 1-methylimidazole in the absence of solvent to give 1a. However, as the alkyl chain in the chloroalkyl nitrile Cl(CH2)nCN precursor increases in length, the temperature required to complete the reaction also increases.
  • Figure US20120108820A1-20120503-C00002
  • Reaction of 1a-4a with a molecular equivalent of HPF6 or NaBF4 affords the imidazolium salts [1-alkylnitrile-3-methylimidazolium][PF6] (n=1-4) 1b -4b and [1-alkylnitrile-3-methylimidazolium][BF4] (n=1-4) 1c-4c, respectively. The imidazolium salts [1-alkylnitrile-3-methylimidazolium]PF65b and [1-alkylnitrile-3-methylimidazolium]E3F4 5c are prepared from 5a using an analogous method. For 1b-5b the salts are washed with water in order to remove the hydrogen chloride formed during the anion exchange reaction, whereas tetrohydrofuran and diethyl ether are used to wash 1c-5c. The salts are then dried under vacuum for 1-2 days. The salts 2c, 3c, 4a, 4b and 3c are liquid at room temperature and are further purified by filtration through silica and left under vacuum at 40-50° C. for several days. All the imidazolium salts are obtained in medium to high yield. They are stable in air and show no signs of decomposition up to 150° C. Some of the ionic liquids within the scope of this invention are listed in the examples and appendix).
  • The synthetic route to prepare ionic liquids with a functionalized anion involves the preparation of the anion as a potassium salt, followed by anion metathesis with various imidazolium halides. The synthesis of e.g. K[BF3CHCH3CH2CN]− is depicted in Scheme 2. The first step of the anion synthesis involves hydroboration of allyl cyanide using boron trichloride and triethylsilane, then addition of water to afford the boronic acid wich is subsequently stirred with KHF2 in ether/H2O at ambient temperature. The product, K[BF3CHCH3CH2CN]−1, is recrystallized from acetone on addition of diethyl ether as colourless needles in 74% yield. Surprisingly alpha-alkene hydroboration affords boronic esters or acids at the alpha-position.
  • Commencing with 1-methylimidazole or 1-trimethylsylilimidazole a series of imidazolium halides 2-10 were prepared. Subsequent metathesis with 1 in acetone give the dual-functionalized ionic liquids 11-19 in yield of 80 to 90%.
  • Figure US20120108820A1-20120503-C00003
    • Uses of the Ionic Liquids
  • These ionic liquids can react with lanthanide and actinide series and transition metal chlorides and other metal salts or compounds used as catalysts to form complexes, for example, with PdCl2, PtCl2, RuCl3, RhCl3, and [Ru(arene)Cl2]2. Included within the term salts are not only the chlorides, but other salts which are known and employed to those skilled in the art. Metal containing molecular compounds used as catalysts, e.g. Wilkinson's catalyst and Grubb's catalyst, or the like can also be employed in this invention.
  • The process of making the complex is a straightforward one of dissolving a catalytically effective amount of the desired catalyst in enough of the ionic liquid to form a solution. If the catalyst and ionic liquid solution is to be used immediately in a catalyzed reaction, the amounts of the two can be those required for the reaction, the ionic liquid serving as solvent for the reaction step immediately following. The reaction product usually is separated from the reactants by solvent extraction, but the immobilized catalyst remains in the ionic liquid solvent, so is recovered and can be used for another reaction. The catalyst can also be prepared in a concentrated form in the ionic liquid, then later diluted with an excess of the ionic liquid to the desired catalyst concentration.
  • Since these complexes form part of the liquid, they are highly soluble in the ionic liquid. Many will catalyze a wide range of organic transformations, like hydrogenation, hydroformylation, metathesis, C—C coupling reactions, dimerization, oligomerization and polymerization.
  • The main advantages of the invention are:
      • 1. The ionic liquids act as both ligand and solvent when used as media for organic synthesis in multiphasic catalysis, therefore, no other ligands are necessary.
      • 2. The catalysts are strongly immobilized in the ionic liquids and can be easily recycled without loss (or minimal loss) of the catalyst.
        The dual-functionalized ionic liquids are particularly advantageous due to their very low viscosities, e.g. as shown in Examples 33 to 35.
  • As noted above, the nitrile derivatized ionic liquids of this invention are useful as solvents for multiphasic catalysis, in terms of catalyst retention and product separation. Dissolution of PdCl2 in [C3CNmim][BF4] 3c affords [Pd(NCC3mim)2Cl2][BF4]2 in quantitative yield. The resulting solution is used to hydrogenate 1,3,-cyclohexadiene under biphasic conditions, which affords cyclohexene and cyclohexane. The overall conversion is 90% and the turnover frequency 247 molmol−1h−1; cyclohexene is formed with a selectivity of 97%. This is possibly because the monoene dissociates from the catalyst and is less soluble in the ionic liquid than the diene, which is therefore hydrogenated in preference. Hydrogenation reactions have been widely studied in ionic liquids, including the substrate 1,3-cyclohexadiene, but this would appear to be the first time selectivity to cyclohexene has been observed. Selective hydrogenation of 1,3-cyclohexadiene using palladium and platinum complexes with chiral ferrocenylamine sulfide and selenide ligands has been reported previously. It is clearly an advantage that the palladium ionic liquids system gives such selectivity without the need for aditional co-ligands. However, the most important feature of this system is that the catalyst is part of the ionic liquid and therefore not easily lost during extraction of the product. No decrease in activity is observed after re-use of the catalyst solution. No palladium residues in the organic phase are detected using inductively coupled plasma analysis.
  • This invention is illustrated by the following examples.
    • EXAMPLES
  • The following examples are given to illustrate the synthesis of these ionic liquids and application in catalysis.
  • The 1-methylimidazole and 1,2-dimethylimidazole and chloronitriles are purchased from Fluke, HPF6 and NaBF4 are purchased from Aldrich and are used as received without further purification. The synthesis of the imidazolium salts 1a-5a is performed under an inert atmosphere of dry nitrogen using standard Schlenk techniques in solvents dried using the appropriate reagents and distilled prior to use. All other compounds are made without precautions to exclude air or moisture. IR spectra are recorded on a Perkin-Elmer FT-IR 2000 system. NMR spectra are measured on a Bruker DMX 400, using SiMe4 for 1H, 85% H3PO4 for 31P, as external standards at 20° C. Electrospray ionization mass spectra (ESI-MS) are recorded on a ThermoFinnigan LCQ™ Deca XP Plus quadrupole ion trap instrument on sample diluted in methanol.19 Samples are infused directly into the source at 5 μL min−1 using a syringe pump and the spray voltage is set at 5 kV and the capillary temperature at 50° C. Samples 2c, 3c, 4a, 4b and 4c are purified by filtration through silica and left under vacuum (ca. 0.1 mm Hg) at 40-50° C. in order to remove traces of salt impurities and volatile components. Differential scanning calorimetry is performed with a SETARAM DSC 131. Density is determined with a picometer at room temperature (20±1° C.) on 1.0 ml of sample. The measurements are repeated three times and average values are used. Viscosities are measured with a Brookfield DV-II+ viscometer on 0.50 ml of sample. The temperature of the samples is maintained to 25±1° C. by means of an external temperature controller. The measurements are performed in duplicate.
    • Example 1 Synthesis of /1-methylnitrile-3-methylimidazolium]Cl 1a
  • A mixture of 1-methylimidazole (8.21 g, 0.10 mol) and ClCH2CN (9.06 g, 0.12 mol) is stirred at room temperature for 24 hours, during which time the reaction mixture turned to a solid. The solid is washed with diethyl ether (3×30 ml) and dried under vacuum for 24 hours, yield: 14.5 g, 92%; M.p. 170° C. Crystals suitable for X-ray diffraction are obtained by slow diffusion of ethyl ether into an acetonitrile solution of the compound at room temperature. ESI-MS (CH3OH): positive ion: 122 [CCNmirn], negative ion: 35 [Cl]. 1NMR (D2O): δ=9.06 (s, 1H), 7.72 (s, 1H), 7.61 (s, 1H), 4.65 (s, 2H), 3.96 (s, 3H). 13C NMR (D2O): δ=140.40, 127.65, 125.52, 117.02, 74.82, 39.54. IR (cm−1): 3177, 3126, 3033 (vC-H aromatic), 2979, 2909, 2838, 2771 (v C-H aliphatic), 2261 (VC≡H ), 1769 (VC≡N). Anal. Calcd for C6H6ClN3 (%): C 45.73, H 5.12, N 22.66; Found: C 45.86, H 5.26, N 22.58.
    • Example 2 Synthesis of [1-methylnitrile-3-methylimidazolium]F6 1b
  • To a solution of 1a (4.73 g, 0.03 mol) in water (50 ml), HPF6 (8.03 g, 60 wt %, 0.033 mol) is added at room temperature. After 10 minutes the solid that had formed is collected by filtration and washed with ice-water (3×15 ml) and then dried under vacuum. Yield: 5.61 g, 70D/o; M.p. 78° C. ESI-MS (CH3OH): positive ion: 122 [CCNmim], negative ion: 145 [PF6]. 1H NMR (CD3CN): δ=8.59 (s, 1H), 7.53 (s, 1H), 7.44 (s, 1H), 5.41 (s, 2H), 3.86 (s, 3H). 13C NMR (CD3CN): δ=139.9, 127.6, 125.5, 120.5, 40.0, 39.3. 31P NMR (CD3CN): −145.25 (hept). IR (cm −1): 3180, 3133, 3027 (VC—H aromatic), 2983, 2938 (VC—H aliphatic), 2274 (VC≡N), 1602 (VC≡N). Anal. Calcd for C6H8N3F6P (%): C 26.98, H 3.02, N 15.73; Found: C 27.02, H 3.09, N 15.66.
    • Example 3 Synthesis of [1-methylnitrile-3-methylimidazolium]BF4 1c
  • A mixture of 1a (4.73 g, 0.03 mol) and NaBF4 (3.62 g, 0.033 mol) in acetone (80 ml) is stirred at room temperature for 48 hours. After filtration and removal of the solvents the resulting pale yellow waxy solid is washed with tetrohydrofuran and diethyl ether to give the product. Yield: 5.76 g, 92%; M.p. 35° C. ESI-MS (CH3OH): positive ion: 122 [CCNmim], negative ion: 87 [BF4]. 1H NMR (CD3CN): δ=8.67 (s, 1H), 7.56 (s, 1H), 7.47 (s, 1H), 5.26 (s, 2H), 3.87 (s, 3H). 13C NMR (CDCl3): δ=140.35, 127.57, 125.46, 116.76, 39.79, 39.21. IR (cm−1): 3171, 3124, 3015 (VC—H aromatic), 2977, 2845 (VC—H aliphatic), 2253 (VC≡N), 1588 (VC≡N). Anal. Calcd for C6H8BF4N3(%): C 34.48, H 3.86, N 20.11; Found: C 34.52, H 3.82, N 20.26.
    • Example 4 Synthesis of [1-ethylnitrile-3-methylimidazolium]Cl 2a
  • A mixture of 1-methylimidazole (8.21 g, 0.10 mmol) and Cl(CH2)2CN (10.74 g, 0.12 mol) is stirred in toluene (20 ml) at 70° C. for 24 hours. The resulting white solid is washed with diethyl ether (5×30 ml). The product is then dried in vacuum for 24 hours. Yield: 15.5 g, 82%; M.p. 50° C. ESI-MS (CH3OH): Positive ion: 136 [C2CNmim], negative ion: 35 [Cl]. 1H NMR (D2O): δ=8.73 (s, 1H), 7.48 (s, 1H), 7.46 (s, 1H), 4.64 (t, J(H, H)=6.8 Hz, 2H), 3.94 (s, 3H), 3.03 (t, J(H, H)=6.8 Hz, 2H); 13C NMR (D2O): δ=139.58, 138.05, 126.16, 122.53, 47.86, 42.12, 38.83. IR (cm1): 3244 (VC—H aromatic), 2916, 2788, 2700 (VC—H aliphatic), 2250 (VC≡H), 1720 (VC≡N). Anal. Calcd for C7H10ClN3 (%): C 48.99, H 5.87, N 24.48; Found: C 50.02, H 5.75, N 24.71.
    • Example 5 Synthesis of [1-ethylnitrile-3-methylimidazolium]PF6 2b
  • The same procedure is followed as that described above for 1b, except 2a (5.15 g, 0.03 mol) and HPF6 (8.03 g, 60 wt %, 0.033 mol) are used, and the product is obtained as a white solid. Yield: 6.83 g, 81%; M.p. 35° C. ESI-MS (CH3OH): Positive ion: 136 [C2CNmim], negative ion: 145 [PF6]. 1H NMR (CD3CN): δ=8.64 (s, 1H) 7.50 (s, 1H), 7.43 (s, 1H), 4.46 (t, J(H, H)=6.49 Hz, 2H), 3.89 (s, 3H), 3.03 (t, J(H, H)=6.49 Hz, 2H). 13C NMR (CD3CN): δ=139.36, 127.13, 125.34, 120.49, 47.87, 39.01, 21.92. 31P NMR (CD3CN): −142.90 (hept). IR (cm−1): 3168, 3126, 3101 (VC—H aromatic), 2964 (vC—H aliphatic), 2255 (VC≡N), 1704 (VC≡N). Anal. Calcd for C7H10F6N3P (%): C 29.90 H 3.58, N 14.95; Found: C 29.95, H 3.62, N 14.88.
    • Example 6 Synthesis of (1-ethylnitrile-3-methylimidazolium]BF4 2c
  • The same procedure is followed as that described above for 1c, except 2a (5.15 g, 0.03 mol) is used instead of 1a. The product is obtained as pale yellow liquid at room temperature. Yield: 5.69 g, 85%; M.p. 20° C. ESI-MS (CH3OH): Positive ion: 136 [C2CNmim], negative ion: 87 [BF4]. 1H NMR (CD3CN,): δ=8.56 (s, 1H), 7.41 (s, 1H), 7.37 (s, 1H), 4.48 (brs, 2H), 3.88 (s, 3H), 3.05 (brs, 2H). 13C NMR (CD3CN): δ=138.33, 126.22, 122.56, 121.04, 47.81, 38.54, 21.81. IR (cm−1): 3165 and 3124 (VC—H aromatic), 2955 and 2855 (VC—H aliphatic), 2251 (VC≡N), 1736 (VC≡N). Anal. Calcd for C7H10N3BF4 (%) C 37.70, H 4.52, N 18.84; Found: C 37.52, H 4.65, N 19.05.
    • Example 7 Synthesis of [1-propylnitrile-3-methylimidazolium]Cl 3a
  • A mixture of 1-methylimidazole (8.21 g, 0.10 mmol) and Cl(CH2)3CN (12.43 g, 0.12 mol) is stirred at 80° C. for 24 hours. The resulting white solid is washed with diethyl ether (3×30 ml). The product is dried in vacuum for 24 hours. Yield: 17.6 g, 95%; M.p. 80° C. ESI-MS (CH3OH): Positive ion: 150 [C3CNmim], negative ion: 35 [Cl]. 1H NMR (CDCl3): δ=8.73 (s, 1H), 7.45 (s, 1H), 7.39 (s, 1H), 4.27 (t, J(H, H)=6.8 Hz, 2H), 3.82 (s, 3H), 2.50 (t, J(H, H)=6.8 Hz, 2H), 2.20 (t, J(H, H)=6.8 Hz, 2H). 13C NMR (CDCl3): δ=134.11, 130.49, 120.01, 116.19, 44.01, 30.87, 21.21, 9.87. IR (cm−1): 3373, 3244, 3055 (vC—H aromatic), 3029, 2974, 2949, 2927 (VC—H aliphatic), 2243 (VC≡N), 1692 (VC≡N). Anal. Calcd for C8H12ClN3 (%): C, 51.76, H, 6.51, N, 22.63; Found: C 51.72, H 6.55, N 22.71.
    • Example 8 Synthesis of (1-propylnitrile-3-methylimidazolium]PF6 3b
  • The same procedure is followed as that described above for 1b, except 3a (5.57 g, 0.03 mol) is used instead of 1a. The product is obtained as white solid. Yield: 6.90 g, 78%; M.p. 75° C. ESI-MS (CH3OH): Positive ion: 150 [C3CNmim], negative ion: 145 [PF6]. 1H NMR (CDCl3): δ=8.63 (s, 1H), 7.59 (s, 1H), 7.55 (s, 1H), 4.42 (t, J(H, H)=7.0 Hz, 2H), 4.03 (s, 3H), 2.66 (t, J(H, H)=7.0 Hz, 2H), 2.33 (m, 2H). 13C NMR (CDCl3): δ=135.50, 131.80, 120.10, 116.50, 44.25, 33.30, 22.50, 9.98. 31P NMR (CDCl3): −145.90 (hept). IR (cm−1): 3171, 3158, 3128 (vC—H aromatic), 2980, 2807 (VC—H aliphatic), 2246 (VC≡N), 1696 ((VC≡N). Anal. Calcd for C8H12F6N3P (%): C 32.55, H 4.10, N 14.24; Found: C 32.59, H 4.11, N 14.30.
    • Example 9 Synthesis of [1-propylnitrile-3-methylimidazolium]BF4 3c
  • The same procedure is followed as that described above for 1c, except 3a (5.57 g, 0.03 mol) is used instead of 1a. Yield: 6.4 g, 90%; M. p. −71.9° C. ESI-MS (CH3OH): Positive ion: 150 [C3CNmim], negative ion: 87 [BF4]. 1H NMR (CDCl3): δ=9.32 (s, 1H), 8.18 (s, 1H), 8.14 (s, 1H), 4.96 (brs, 2H), 4.54 (s, 3H), 3.20 (brs, 2H), 2.85 (brs, 2H), 13C NMR (CDCl3): δ=135.03, 131.17, 120.69, 116.71, 44.69, 33.78, 22.01, 10.15. 1R (cm−1): 3161, 3121 (VC—H aromatic), 2971 (VC—H aliphatic), 2249 (VC≡N), 1712 (VC≡N). Anal. Calcd for C8F4BH12N3 (%): C 40.54, H 5.10, N 17.73; Found: C 40.58, H 5.13, N 17.69.
    • Example 10 Synthesis of [1-butylnitrile-3-methylimidazolium]Cl 4a
  • A mixture of 1-methylimidazole (8.21 g, 0.10 mmol) and Cl(CH2)4CN (14.1 g, 0.12 mol) is stirred at 80° C. for 4 hours. The temperature is then increased to 110° C. and the reaction mixture is stirred at for further 2 hours. After cooling, the reaction mixture is washed with diethyl ether (3 x15 ml) and dried under vacuum for 24 hours. The product is obtained as viscous brownish liquid. Yield: 17.9 g, 90%; M.p. 32° C. ESI-MS (CH3OH): Positive ion: 164 [C4CNmirn], negative ion: 35 [Cl], 1H NMR (CD3CN): δ=9.99 (s, 1H), 7.75 (s, 1H), 7.70 (s, 1H), 4.41 (t, J(H, H)=7.2 Hz, 2H), 3.94 (s, 3H), 2.57 (t, J(H, H)=7.0 Hz, 2H), 2.07 (m, J(H, H)=6.8 Hz, 2H), 1.64 (m, J(H, H)=6.8 Hz, 2H). 13C NMR (CD3CN): δ=134.22, 129.29, 127.97, 125.81, 123.18, 41.50, 34.43, 27.47, 21.77. IR (cm−1): 3138, 3088, 3082 (VC—H aromatic), 2948 (VC—H aliphatic), 2241 (VC≡N), 1701 ((VC≡N). Anal Calcd for C9H14ClN3(%): C 54.13, H 7.07, N, 21.04; Found: C 54.21, H 7.09, N, 21.09.
    • Example 11 Synthesis of [1-butylnitrile-3-methylimidazolium]F6 4b
  • The same procedure is followed as that described above for 1b, except 4a (5.99 g, 0.03 mol) is used instead of 1a. The product is obtained as brown liquid at room temperature. Yield: 7.6 g, 82%; M.p. −60.3° C. ESI-MS (CH3OH): positive ion: 164 [C3CNmim], negative ion: 145 [PF6]. 1H NMR (CD3CN): δ=8.45 (s, 1H), 7.38 (s, 1H), 7.35 (s, 1H), 4.15 (t, J(H, H)=7.17 Hz, 2H), 3.83 (s, 3H), 2.44 (t, J(H, H)=7.17 Hz, 2H), 1.93 (m, J(H, H)=7.17, 2H), 1.64 (m, J(H, H)=7.17, 2H). 13C NMR (CD3CN): δ=138.95, 126.72, 125.16, 122.85, 120.80, 38.78, 31.61, 24.74, 18.93. 31P NMR (CDCl3): −140.80 (hept). IR (cm−1): 3168, 3123 (VC—H aromatic), 2972, 2901 (VC—H aliphatic), 2250 (VC≡N), 1577 ((VC≡N). Anal. Calcd for C9F6H14N3P (%): C 34.96, H 4.56, N 13.59; Found: C 35.05, H 4.41, N 13.64.
    • Example 12 Synthesis of [1-butylnitrile-3-methylimidazolium]3F4 4c
  • The same procedure is followed as that described above for 1c, except 4a (5.99 g, 0.03 mol) is used instead of 1a. The product is obtained as brown liquid at room temperature. Yield: 6.4 g, 85%; M.p. −71.9° C. ESI-MS (CH3OH): Positive ion: 164 [C3CNmirn], negative ion: 87 [BF4]. 1H NMR (CD3CN): δ=8.54 (s, 1H), 7.43 (s, 1H), 7.39 (s, 1H), 4.17 (brs, 2H), 3.83 (s, 3H), 2.44 (brs, 2H), 1.92 (brs, 2H), 1.60 (brs, 2H). 13C NMR (CD3CN): δ=139.24, 131.19, 128.02, 126.68, 123.72, 38.69, 31.64, 24.70, 18.64. IR (cm−1): 3161, 3120 (VC—H aromatic), 2955, 2876 (VC—H aliphatic), 2247 (VC≡N), 1575 (VC≡N). Anal. Calcd for C9H14N3BF4 (%): C 43.06, H 5.62, N 16.74; Found: C 43.12, H 5.53, N 16.70.
    • Example 13 Synthesis of [1-methylnitrile-2,3-dimethylimidazolium]Cl 5a
  • A mixture of 1,2-dimethylimidazole (9.61 g, 0.10 mol) and Cl(CH2)3CN (12.43 g, 0.12 mol) is stirred at 100° C. for 24 hours. Two phases are formed at the end of the reaction. The upper phase is decanted and the lower phase is washed with diethyl ether (3×30 ml). A pale yellow solid is formed during the washing and the product is dried in vacuum for 24 hours at room temperature. Yield: 18.6 g, 93%; M.p. 105° C.×(CH3OH): Positive ion: 164 [C3CNdimim], negative ion: 35 [Cl]. 1H NMR (CD3CN): δ=7.50 (s, 1H), 7.31 (s, 1H), 4.14 (t, J(H, H)=7.17 Hz, 2H), 3.71 (s, 3H), 2.53 (s, 3H), 2.46 (t, J(H, H)=7.17 Hz, 2H), 2.11 (m, J(H, H)=7.17 Hz, 2H). 13C NMR (CD3CN): δ=125.52, 123.70, 122.32, 120.73, 49.47, 37.66, 28.12, 16.50, 11.92. IR (cm−1): 3182, 3098, 3046 (VC—H aromatic), 2989, 2898, 2834 (VC—H aliphatic), 2240 (VC≡N), 1631 (VC≡N). Anal. Calcd for C9H14ClN3 (%) C 54.13, H 7.07, N 21.04; Found: C 54.18, H 7.17, N 20.92.
    • Example 14 Synthesis of [1-methylnitrile-2,3-dimethylimidazolium]PF6 5b
  • The same procedure is followed as that described above for 1b, except 5a (5.99 g, 0.03 mol) is used instead of 1a. The product is obtained as white solid at room temperature. Yield: 7.33 g, 79%; M.p. 85° C. ESI-MS (CH3OH): Positive ion: 164 [C3CNdimim], negative ion: 145 [PF6]. 1H NMR (CD3CN): δ=7.34 (s, 1H), 7.32 (s, 1H), 4.18 (t, J(H, H)=7.17 Hz, 2H), 3.75 (s, 3H), 2.55 (s, 3H), 2.51 (t, J(H, H)=7.17 Hz, 2H), 2.14 (m, J(H, H)=7.17, 2H). 13C NMR (CD3CN): δ=144.91, 122.87, 120.99, 120.59, 46.85, 35.08, 25.02, 14.09, 9.37. 31P NMR (CD3CN): −140.80 (hept). IR (cm 1): 3150 (VC—H aromatic), 2966 (VC—H aliphatic), 2249 (VC≡N), 1628 (VC≡N). Anal. Calcd for C9F6H14N3P (%): C 34.96, H 4.56, N 13.59; Found: C 35.02, H 4.52, N 13.61.
    • Example 15 Synthesis of [1-methylnitrile-2,3-dimethylimidazolium]BF4 5c
  • The same procedure is followed as that described above for 1c, except 5a (5.99 g, 0.03 mol) is used instead of 1a. The product is obtained as white waxy solid at room temperature. Yield: 6.77 g, 90%; M.p. 40° C. ESI-MS (CH3OH): Positive ion: 164 [C3CNdimim], negative ion: 87 [BF4]. 1H NMR (CD3CN): δ=7.31 (s, 1H), 7.30 (s, 1H), 4.15 (t, J(H, H)=6.84 Hz, 2H), 3.72 (s, 3H), 2.59 (s, 3H), 2.47 (t, J(H, H)=6.84, 2H), 2.13 (m, J(H, H)=6.84, 2H). 13C NMR (CD3CN): δ=125.54, 123.70, 122.08, 120.52, 49.51, 37.71, 28.04, 16.59, 11.98. IR (cm−1) 3185, 3145 (VC—H aromatic), 2966 (VC—H aliphatic), 2244 (VC≡N), 1701 ((VC≡N). Anal. Calcd for C9H1413F4N3 (%): C 43.06, H 5.62, N 16.74; Found: C 42.85, H 5.75, N 16.68.
    • Example 16 Synthesis of [Pd(1-methylnitrile-2,3-dimethylimidazolium)2Cl][BF4]2
  • A mixture of 5c (153 mg, 0.61 mmol) and palladium chloride (54 mg, 0.305 mmol) in 5.0 ml dichloromethane is stirred at room temperature for 3 days. The resulting yellow solid is extracted by filtration, washed with diethyl ether (2×5.0 ml) and dried in vacuum. Yield: 195 mg, 94%; M.p.: 130° C.; 1H NMR (DMSO): δ=7.62 (s, 1H), 7.61 (s, 1H), 4.16 (t, J(H, H)=7.17 Hz, 2H), 3.72 (s, 3H), 2.57 (s, 3H), 2.56 (brs, 3H), 2.06 (m, J(H, H)=7.17 Hz,2H); 13C NMR (DMSO): δ=148.10, 125.91, 124.20, 123.16, 49.61, 38.09, 28.39, 16.81 and 12.60; Anal. Calcd for C18H28B2Cl2F8N6Pd (%): C 31.82, H 4.15, N 12.37; Found: C 31.75, H 4.10, N 12.34; IR (cm−1): 3152 and 3120 (VC—H aromatic), 2988, 2973 and 2901 (VC—H aliphatic), 2325 (VC≡N), 1692 ((VC≡N).
    • Example 17 Synthesis of [1-cyanopropyl-3-methylimidazolum]2[PdCl4]
  • A reaction mixture of Pda2(177 mg, 1.0 mmol) and 3a (377 mg, 2.00 mmol) in dichloromethane (2 ml) is stirred at r.t. for 4 days. The resulting orange solid is collected by centrifugation and washed with dichloromethane (20 ml). Drying in vacuum gave the product in pure form. Yield: 548 mg, 100%. Mp: 178° C. 1H NMR (DMSO-d6): 2.18 (t, 2H), 2.64 (t, 2H), 3.89 (s, 3H), 4.32 (t, 2H), 7.79 (s, 1H), 7.87 (s, 1H), 9.37 (s, 1H). 13C NMR (DMSO-d6): 135.28, 131.36, 120.13, 116.18, 44.02, 31.22, 21.77, 9.99. Microanalysis: Found (Calc.): C 35.03 (35.07), H 4.41 (4.44), N 15.32 (15.29)%. IR (cm−1): UCN, 2241(s). The compound could be dissolved in ionic liquids and used as a catalyst, the results in the hydrogenation of 1,3-cyclohexadiene are similar to those obtained in EXAMPLE 19.
    • Example 18 Synthesis of [(1-cyanopropyl-3-methylimidazolum)2PdCl2][BF4]2
  • A reaction mixture of PdCl2 (177 mg, 1.0 mmol) and (474 mg, 2.00 mmol) [C3CNmim][BF4] 3c in dichloromethane (2 ml) is stirred at room temperature for 4 days. The resulting pale yellow solid is collected by centrifugation and washed with dichloromethane (20 ml). Drying in vacuum gave the product in pure form. Yield: 99%. M.p.: 80° C. 1H NMR (DMSO-d5): 2.18 (m, 2H), 2.58 (t, 2H), 3.86 (s, 3H), 4.25 (t, 2H), 7.71 (s, 1H), 7.77 (s, 1H), 9.09 (s, 1H). 13C NMR (DMSO-d6): 132.12, 120.15, 118.69, 116.09, 44.08, 33.35, 27.87, 9.84. Microanalysis: Found (Calc.): C 29.51 (29.50), H 3.74 (3.71), N 12.88 (12.90)%. IR (cm−1): 3159, 3112 (Vc.H aromatic), 2933 (VC—H aliphatic), 2324 (VC≡N), 1721 (VC≡N); this compound can be dissolved in ionic liquids and used as a catalyst, the results in the hydrogenation of 1,3-cyclohexadiene are similar to those obtained in EXAMPLE 19.
    • Example 19 Hydrogenation of 1,3-cyclohexadiene by PdCl2 in 3c
  • PdCl2 (˜5 mg) is dissolved in ionic liquid 3c (1 ml), and 1,3-cyclohexadiene (1 ml) is added. The reaction is pressurized with H2 to 45 atm, sealed and heated to 100° C. for 4 h which gave cyclohexene in 90% yield. The product is simply removed by decantation and no palladium is detected (based on ICP analysis).
    • Example 20 Comparison of Suzuki Reactions Carried out in (C4mim][BF4] and [C3CNmim][BF4] (Depicted in Scheme 3)
  • Figure US20120108820A1-20120503-C00004
  • Complexes 7a, 7b, 7c are used for Suzuki coupling reaction of iodobenzene and benzeneboronic acid, as shown in scheme 2, above. lodobenzene (2.5 mmol, 1 equiv.), benzenboronic acid (2.75 mmol, 1.1 equiv.), Na2CO3 (560 mg, 5.28 mmol, 2.1 equiv.), palladium complex (0.03 mmol) and water (2.5 ml) are mixed with [C4mim][BF4] (5 ml). The mixture is heated to 110° C. with vigorous stirring for 12 hours, then cooled and extracted with diethyl ether (3×15 ml). The combined organic phase is dried over MgSO4 and filtered. The product, biphenyl, is obtained in 100% yield. If a nitrile ionic liquid, [C3CNmim][BF4], is used in place of the [C4mim][BF4], a similar yield is obtained. Significantly, using [C3CNmim][18F4) the yields can be maintained at above 90% even after six runs of catalysis, while yields decrease rapidly for [C4mim][BF4]. Dissolving PdCl2 in the [C3CNmim][BF4] gives the same result as using complexes 6 and 7.
    • Examples 21 to 32 describe the dual-functionalized ionic liquids with the [BF3CHCH3CH2CNr anion. Example 21 Synthesis of 3 (R═CH2CH═CH2, X═Br)
  • A mixture of 1-methylimidazole (8.21 g, 0.10 mol) and propenyl bromide (12.1 g, 0.10 mol) in methanol (50 ml) is stirred at room temperature for 5 days. The solvent is removed under reduced pressure. The resulting pale yellow viscous liquid is washed with diethyl ether (3'100 ml) and then dried in vacuum. Yield: 18.67 g, 92%; m.p.: −52.5° C.; ESI-MS (H2O, m/z): positive ion, 123, [CH2CH═CH2mim]+; negative ion, 80, [Br]−; 1H NMR (D2O): δ 8.79 (s, 1H), 7.62 (s, 1H), 7.60 (s, 1H), 6.15 (m, 1H), 5.50 (m, 1H), 4.96 (m, 2H), 4.05 (s, 3H); 13C NMR (D2O): 136.1, 130.7, 124.5, 122.8, 121.5, 51.8, 36.3; Anal. Calcd. for C7H11N2Sr (%): C 41.40, H 5.46, N, 13.79; Found: C 40.41, H 5.41, N 13.27.
    • Example 22 Synthesis of 7 (R═CH2CH═CH2, X═Br)
  • A mixture of 1-allylimidazole (10.8 g, 0.10 mmol) and propenyl bromide (12.1 g, 0.10 mol) in methanol (50 ml) is stirred at room temperature for 5 days. The solvent is removed under reduced pressure. The resulting pale yellow viscous liquid is washed with diethyl ether (3×30 mL). The product is dried in vacuum for 24 h. Yield: 19.3 g, 95%; m.p.: −26.50□C. ESI-MS (H2O, m/z): positive ion, 149 [DiCH2CH≡CH2im]+; negative ion, 80 [Br]−; 1H NMR (D2O): δ 9.20 (s, 1H). 7.85 (s, 2H), 6.20 (m, 2H), 5.55 (m, 4H), 5.10 (m, 4H); 13C NMR (D2O): 135.5, 130.5, 123.1, 122.0, 51.9; Anal. Calcd. for C7H11N2Br (%): C 41.40, H 5.46, N, 13.79. Found: C 40.41, H 5.41, N 13.27.
    • Example 23 Synthesis of 10 (R═CH2CH2CH2C≡N, X═Cl)
  • A mixture of trimethysilyimidazole (14.03 g, 0.10 mol) and Cl(CH2)3CN (24.86 g, 0.24 mol) wis stirred at 80° C. for 24 h. The resulting white solid is washed with diethyl ether (3×30 mL). The product is dried in vacuum for 24 h. Yield: 22.4 g, 94%; m.p.: 1001□C. ESI-MS (H2O, m/z): positive ion, 203 [Di(CH2)3C≡Nim]+; negative ion, 35, 37 [Cl]−; 1H NMR (D2O): δ 8.56 (s, 1H), 7.52 (s, 2H), 4.48 (t, 4H, 3J(H, H)=7.15 Hz), 2.66 (m, 4H), 2.35 (t, 4H, 3J(H, H)=7.15 Hz); 13C NMR (D2O): 137.10, 123.4, 119.2, 48.3, 29.3, 25.1; IR (cm−1): 3166, 3075, 2939, 2895, 2839, 2241, 1781, 1669, 1570, 1559; Anal. Calcd for C11H15ClN4 (%): C 55.35, H 6.33, N 23.47. Found: C 54.98, H 6.08, N 23.55.
    • Example 24 Synthesis of 11 (R1═CH2CH2CH2CH3, R2═CH3)
  • A mixture of 1 (1.0 g, 5.71 mmol) and 2 (1.0 g, 5.71 mmol) is stirred in acetone at room temperature for 24 h. The resulting suspension is filtered and the filtrate dried in vacuum. The resulting ionic liquid is purified by washing with diethyl ether, and the solvents removed in vacuo. Yield: 1.32 g, 84%. Pale yellow liquid, m.p.: −84.5° C.; ESI-MS (H2O, m/z): positive ion, 139, [C4min]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ 8.28 (s, 1H), 7.16 (s, 1H), 7.11 (s, 1H), 4.45 (t, 3J(H, H)=7.15 Hz, 2H), 3.85 (s, 3H), 2.35-1.94 (m, 4H), 1.92-1.85 (m, 2H), 1.32 (t, 3H, 3J(H, H)=6.98 Hz), 1.20 (m, 2H), 0.89 (d, 3H, 3J(H, H)=7.3 Hz), 0.56 (m, 1H); 13C NMR (d6-acetone): δ 136.8, 126.3, 124.5, 121.7, 49.0, 35.7, 31.9, 29.2, 20.6, 19.6, 15.5, 13.0; 19F NMR (d6-acetone): −149.8 (m); IR (cm−1): 3154, 3117, 2962, 2872, 2239, 1574; Anal. Calcd. for Cl2H21BF3F3N3 (%): C 52.39, H 7.69, N, 15.27. Found: C 52.38, H 7.41, N 15.51.
    • Example 25 Synthesis of 12 (R1═CH2CH═CH2, R2═CH3)
  • The same method is used as in the synthesis of 11 except 3 (1.16 g, 5.71 mmol) is used in place of 2. Yield: 1.30 g, 88%. Pale yellow liquid, m. p.: −89.2° C.; ESI-MS (H2O, m/z): positive ion, 123, [CH2CH═CH2mim]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ 8.89 (s, 1H), 7.67 (s, 1H), 7.66 (s, 1H), 6.07 (m, 1H), 5.58 (m, 1H), 4.92 (m, 1H), 4.61 (s, 3H), 3.95 (s, 2H), 2.34 (dd, 1H, 2J(H, H)=−17.1 Hz, 3J(H, H)=4.3 Hz), 1.96 (dd, 1H, 2J(H, H)=−17.1, 3J(H, H)=10.7 Hz), 0.87 (d, 3H, 3J(H, H)=7.3 Hz), 0.54 (m, 1H); 13C NMR (d6-acetone): 139.01, 136.7, 124.89, 122.7, 121.5, 121.7, 51.3, 35.9, 28.5, 20.2, 14.8; 13F NMR (d6-acetone): −147.4 (m); IR (cm−1): 3151, 3114, 1647, 2943, 2865, 2238, 1708, 1647, 1574; Anal. Calcd. for C11H17BF3N3 (%): C 51.00, H 6.61, N, 16.22; Found: C 51.21, H 6.45, N 16.17.
    • Example 26 Synthesis of 13 (R1═CH2C≡CH, R2═CH3)
  • The same method is used as in the synthesis of 11 except 4 (1.15 g, 5.71 mmol) is used in place of 2. Yield: 1.20 g, 82%. Pale yellow liquid, m.p.: −80.4° C.; ESI-MS (H2O, m/z): positive ion, 121, [CH2C≡CHmim]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ 9.49 (s, 1H). 7.87 (s, 1H), 7.58 (s, 1H), 5.40 (d, 2H, 4J(H, H)=2.80 Hz), 4.37 (s, 3H), 3.21 (d, 4H, 4J(H, H)=2.80 Hz); 2.36 (dd, 1H, 2J(H, H)=−17.1 Hz, 3J(H, H)=4.3 Hz), 1.91 (dd, 1H, 2J(H, H)=−17.1, 3J(H, H)=10.7 Hz), 0.89 (d, 3H, 3J(H, H)=7.3 Hz), 0.54 (m, 1H); 13C NMR (acetone): δ 137.2, 124.2, 122.2, 121.2, 78.2, 75.2, 35.9, 29.3, 28.7, 20.5, 15.1; 19F NMR (d6-acetone): −148.8 (m); IR (cm 1): 3252, 3156, 3116, 2960, 2867, 2238, 2131, 1697, 1625, 1576, 1459, 1425; Anal. Calcd. for C11H15BF3N3 (%): C 51.40, H 5.88, N, 16.35. Found: C 51.21, H 5.75, N 16.32.
    • Example 27 Synthesis of 14 (R1═CH2CH2CH2COOH, R2═CH3)
  • The same method is used as synthesis of 11 except 5 (1.17 g, 5.71 mmol) is used in place of 2. Yield: 1.53 g, 88%. Colourless liquid, m.p.: −58.6° C.; ESI-MS (H2O, m/z): positive ion, 169, [CH2CH2CH2COOHmim]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ 10.33 (br, 1H), 9,01 (s, 1H), 7.75 (s, 1H), 7.72 (s, 1H), 4.35 (t, 2H, 3J(H, H)=7.05 Hz), 4.00 (s, 3H), 2.17 (t, 2H, 3J(H,H)=7.05), 2.39-1.96 (m, 2H), 0.89 (d, 3H, 3J(H, H)=7.3 Hz), 0.55 (m, 1H); 13C NMR (d6-acetone): δ=173.7, 136.0, 124.6, 121.1, 48.46, 35.1, 30.9, 28.9, 20.5, 15.1; 19F NMR (d6-acetone): −148.8 (m); IR (cm−1): 3155, 3117, 2943, 2867, 2238, 1728, 1566, 1460; Anal. Calcd. for C12H19BF3N3O2(%): C 47.24, H 6.28, N, 13.77; Found: C 471.21, H 6.75, N 13.32.
    • Example 28 Synthesis of 15 (R1═CH2CH2CH2C≡N, R2═CH3)
  • The same method is used as in the synthesis of 11 except 6 (1.06 g, 5.71 mmol) is used in place of 2. Yield: 1.39 g, 85%. Pale yellow liquid, m.p.: −76.6° C.; ESI-MS (H2O, m/z): positive ion, 150 [CH2CH2CH2CNmim]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ=8.75 (s, 1H), 7.44 (s, 1H), 7.39 (s, 1H), 4.45 (t, 2H, 3J(H, H)=7.15 Hz), 4.00 (s, 3H), 2.64 (t, 2H, 3J(H, H)=7.15 Hz), 2.31 (t, 2H, 1J(H, H)=7.14 Hz), 2.30 (m, 1H), 1.98 (dd, 1H, 2J(H, H)=−17.1, 3J(H, H)=10.7 Hz), 0.87 (d, 3H, 3J(H, H)=7.3 Hz), 0.55 (m, 1H); 13C NMR (d6-acetone): δ 134.11, 130.49, 120.0, 121.5, 116.1, 48.0, 30.8, 28.9, 25.9, 20.5, 13.6, 9.8; 19F NMR (d6-acetone): −148.8 (m); IR (cm−1): 3156, 3116, 2960, 2866, 2239, 1631, 1575, 1566, 1459, 1425; Anal. Calcd. for C12H18BF3F3N4 (%): C 50.38, H 6.34, N, 19.58; Found: C 50.21, H 6.45, N 19.32.
    • Example 29 Synthesis of 16 (R1═R2═CH2CH═CH2)
  • The same method is used as in the synthesis of 11 except 7 (1.31 g, 5.71 mmol) is used in place of 2. Yield: 1.43 g, 88%. Pale yellow liquid, m.p.: −87.3° C.; ESI-MS (H2O, m/z): positive ion, 149 [DiCH2CH═CH2im]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ 9.25 (s, 1H). 7.86 (s, 2H), 6.11 (m, 2H), 5.45-5.35 (m, 4H), 4.99 (m, 4H), 2.31 (dd, 1H, 2J(H, H)=−17.1 Hz, 3J(H, H)=4.3 Hz), 1.95 (dd, 1H, 2J(H, H)=−17.1, 3J(H, H)=10.7 Hz), 1.20 (m, 2H), 0.88 (d, 3H, 3J(H, H)=7.3 Hz), 0.56 (m, 1H); 13C NMR (d6-acetone): δ 136.0, 131.7, 122.07, 121.7, 120.8, 51.4, 29.4, 20.6, 15.3; 19F NMR (d6-acetone): −149.8 (m); R (cm): 3143, 3087, 2943, 2866, 2238, 1646, 1562, 1451, 1424; Anal. Calcd. for C13H19BF3F3N3(%): C 54.76, H 6.72, N, 14.74. Found: C 54.21, H 6.85, N 14.41.
    • Example 30 Synthesis of 17 (R1═R2═CH2C≡CH)
  • The same method is used as in the synthesis of 11 except 8 (1.03 g, 5.71 mmol) is used in place of 2. Yield: 1.38 g, 86%. Pale yellow liquid, m.p.: −55.1° C.; ESI-MS (H2O, m/z): positive ion, 145 [DiCH2C≡CHim]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (D2O): δ=9.36 (s, 1H), 7.90 (s, 2H), 5.97 (d, 4H, 4J(H, H)=4.0 Hz), 3.36 (t, 2H, 4J(H, H)=4.0 Hz), 2.35 (dd, 1H, 2J(H, H)=−17.1 Hz, 3J(H, H)=4.3 Hz), 1.94 (dd, 1H, 2J(H, H)=−17.1, 3J(H, H)=10.7 Hz), 0.89 (d, 3H, 3J(H, H)=7.3 Hz), 0.56 (m, 1H); 13C NMR (D2O): δ 138.9, 125.7, 121.7, 81.1, 74.8, 42.5, 29.2, 20.5, 15.4; 19F NMR (d6-acetone): −149.8 (m); IR (cm−1): 3255, 3145, 2944, 2867, 2239, 2131, 1559, 1445; Anal. Calcd. for C13H15BF3N3(%): C 55.55, H 5.38, N, 14.95; Found: C 55.21, H 5.45, N 14.69.
    • Example 31 Synthesis of 18 (R1═R2═CH2CH2CH2COOH)
  • The same method is used as in the synthesis of 11 except 9 (1.58 g, 5.71 mmol) is used in place of 2 as waxy solid. Yield: 1.83 g, 85%. ESI-MS (H2O, m/z): positive ion, 241, [DiCH2CH2CH2COOHim]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ 8.76 (s, 1H), 7.44 (s, 2H), 4.08 (t, 4H, 3J(H, H)=7.05 Hz), 2.38-2.30 (m, 1H) 2.37 (t, 4H, 3J(H, H)=7.05 Hz), 2.08 (m, 4H), 1.97 (dd, 1H, 2J(H, H)=−17.1, 3J(H, H)=10.7 Hz), 1.21 (m, 2H), 0.90 (d, 3H, 3J(H, H)=7.3 Hz), 0.59 (m, 1H); 13C NMR (d6-acetone): δ 179.7, 138.5, 125.5, 121.8, 51.6, 33.1, 28.4, 27.5, 20.3, 14.9; 19F NMR (d6-acetone): −149.8 (m); IR (cm−1): 3607, 3454, 3151, 2946, 2873, 2246, 1727, 1651, 1565, 1460, 1421, 1308; Anal. Calcd. for C15H23BF3N3O4(%); C 47.77, H 6.15, N, 11.14. Found: C 47.35, H 6.25, N 11.38.
    • Example 32 Synthesis of 19 (R1═R2═CH2CH2CH2C≡N)
  • The same method is used as in the synthesis of 11 except 10 (1.39 g, 5.71 mmol) is used in place of 2. Yield: 1.68 g, 87%. Colourless liquid, m.p.: −69.8° C.; ESI-MS (H2O, m/z): positive ion, 203 [Di(CH2)3C≡Nim]+; negative ion, 136, [CH3(BF3)CHCH2CN]−; 1H NMR (d6-acetone): δ 9.30 (s, 1H), 7.83 (s, 2H), 4.46 (t, 4H, 3J(H, H)=7.10 Hz), 2.66 (m, 4H), 2.32 (t, 4H, 3J(H, H)=7.00 Hz), 2.34 (dd, 1H, 2J(H, H)=−17.1 Hz, 3J(H, H)=4.3 Hz), 1.99 (dd, 1H, 2J(H, H)=−17.1 Hz, 3J(H, H)=10.7 Hz), 0.91 (d, 3H, 3J(H, H)=7.3 Hz), 0.58 (m, 1H); 13C NMR (d6-acetone): 137.0, 123.4, 121.9, 119.2, 48.3, 29.3, 29.1, 25.1, 20.6, 13.6; 19F NMR (d6-acetone): −148.8 (m); IR (cm−1): 3148, 3117, 2967, 2247, 1567, 1461, 1425; Anal. Calcd. for C15H21BF3N5(%): C 53.12, H 6.24, N, 20.65. Found: C 52.97, H 6.25, N 20.34.
  • The stability of the nitrile-functionalised anion towards catalytic hydrogenation is tested by pressurising a solution of K[CH3CH(BF3)CH2CN] (8 mg) and RuCl2(PMe3)4 (1 mg) in acetone (0.4 ml) with H2 (40 bar) at 35° C. No reduction was observed even after 48 hours.
    • Example 33
  • Melting Point Data
  • Entry Cation Anion Melting Point (° C.)
    1a [CCNmim] Cl 170
    1b [CCNmim] PF6 78
    1c [CCNmim] BF4 35
    2a [C2CNmim] Cl 50
    2b [C2CNmim] PF6 35
    2c [C2CNmim] BF4 20
    3a [C3CNmim] Cl 80
    3b [C3CNmim] PF6 75
    3c [C3CNmim] BF4 −71.9
    4a [C4CNmim] Cl 32
    4b [C4CNmim] PF6 −60.3
    4c [C4CNmim] BF4 −74.5
    5a [C4CNdimim] Cl 105
    5b [C4CNdimim] PF6 85
    5c [C4CNdimim] BF4 40
    • Example 34
  • Density, Viscosity and Solubility in Common Solvents
  • Density Viscosity Solubility in common solvents
    Entry Ionic liquids (g · ml−1) (mpa · s) H2O Et2O EtOH Acetone Hexane
    1 [C2CNmim][Cl] 2.67 2856 miscible immiscible miscible immiscible immiscible
    2 [C2CNmim][BF4] 2.15 65.5 miscible immiscible miscible miscible immiscible
    3 [C3CNmim][BF4] 1.87 230 miscible immiscible immiscible miscible immiscible
    4 [C4CNmim][Cl] 1.61 5222 miscible immiscible miscible immiscible immiscible
    5 [C4CNmim][PF6] 1.99 2181 partly immiscible immiscible miscible immiscible
    miscible
    6 [C4CNmim][BF4] 1.71 552.9 miscible immiscible immiscible miscible immiscible
    7 [C4mim][PF6] 1.37 320.3 partly immiscible partly miscible immiscible
    miscible miscible
    8 [C4mim][BF4] 1.14 115.2 miscible immiscible immiscible miscible immiscible
    • Example 35
  • Comparison of the melting point and viscosity data of the DF-ILs with tetrafluoroborate counterparts.
  • Melting Viscosity
    Ionic liquidsa Point (° C.) (cp, 20° C.)
    11 −84.5 101.4
    [C4mim][BF4]2 −81.0 115.2
    12 −89.2 25.8
    [CC═Cmim][BF4]5b −81.1 6110
    13 −80.4 175.1
    14 −58.6 3047
    [C3COOHmim][BF4] −58.0 4415
    15 −76.6 107.5
    [C3CNmim][BF4]4 −71.9 230.0
    16 −87.3 56.8
    17 −55.1 1797
    [DiCC≡Cmim][BF4]3b 67.0 —
    18 38.0 —
    19 −69.8 402.4
    a[C4mim][BF4]: 1-methyl-3-butylimidazolium tetrafluoroborate; [CC═Cmim][BF4]: 1-methyl-3-allylimidazolium tetrafluoroborate; [DiCC≡Cmim][BF4]: 1,3-di-akylimidazolium tetrafluoroborate; [C3COOHmim][BF4]: 1-methyl-3-proylcarboxylimidazolium tetrafluoroborate.

Claims (7)

1. Chemical compounds of the general formula,

K+A−,
in which K+ is a 5- or 6-membered heterocyclic ring having 1-3 hetero atoms, which can be independently N, S, or O;
with the proviso that at least one of the hetero atoms must be a quaternized nitrogen atom having a —R′CN substituent, wherein R′ is alkyl (C1 to C12);
the heterocyclic ring having up to 4 or 5 substituents independently chosen from the moieties:
(i) H;
(ii) halogen or
(iii) alkyl (C1 to C12), which is unsubstituted or partially or fully substituted by further groups, preferably F, Cl, N(CnF(2n+1−x)Hx)2, O(CnF(2n+1−x)Hx), SO2(CnF(2n+1−x)Hx)2 or CnF(2n+1−x)Hx where 1<n<6 and 0<x<13; and
(iv) a phenyl ring which is unsubstituted or partially or fully substituted by further groups, preferably F, Cl, N(CnF(2n+1−x)Hx)2, O(CnF(2n+1−x)Hx), SO2(CnF(2n+1−x)Hx)2 or CnF(2n+1−x)Hx where 1<n<6 and 0<x≦13; and
A− is halide, such as chloride, bromide, fluoride and the like; BF4 −, PF6 −, NO3 −, CH3CO2 −, CF3SO3 −, (CF3SO2)2N−, (CF3SO2)3C−, CF3CO2 − or N(CN)2 −.
2. The compound of claim 1 in which the heterocyclic ring is the pyrrolium, pyrazolium, pyridinium, pyrazinium, pyrimidinium, pyrazinium, imidazolium, thiazolium, oxazolium, or triazolium.
3. The compound of claim 2 in which the heterocyclic ring is the pyridinium or imidazolium.
4. The compound of claim 1 in which the anion is chloride.
5. The compound of claim 1 in which the anion is BF4 or PF6.
6. The compound of claim 1 complexed with PdClwhich the anion is BF4.
7. The compound of claim 1 complexed with PdCl2, PtCl2, RuCl3, RhCl3, or [Ru(arene)Cl2]2.
US13/328,353 2003-08-26 2011-12-16 Ionic liquids based on imidazolium salts incorporating a nitrile functionality Abandoned US20120108820A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/328,353 US20120108820A1 (en) 2003-08-26 2011-12-16 Ionic liquids based on imidazolium salts incorporating a nitrile functionality

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49777603P 2003-08-26 2003-08-26
PCT/EP2004/009499 WO2005019185A1 (en) 2003-08-26 2004-08-25 Ionic liquids based on imidazolium salts incorporating a nitrile functionality
US8774908A 2008-11-10 2008-11-10
US13/328,353 US20120108820A1 (en) 2003-08-26 2011-12-16 Ionic liquids based on imidazolium salts incorporating a nitrile functionality

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2004/009499 Division WO2005019185A1 (en) 2003-08-26 2004-08-25 Ionic liquids based on imidazolium salts incorporating a nitrile functionality
US8774908A Division 2003-08-26 2008-11-10

Publications (1)

Publication Number Publication Date
US20120108820A1 true US20120108820A1 (en) 2012-05-03

Family

ID=34216151

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/087,749 Expired - Fee Related US8101777B2 (en) 2003-08-26 2004-08-25 Ionic liquids based on imidazolium salts incorporating a nitrile functionality
US13/328,353 Abandoned US20120108820A1 (en) 2003-08-26 2011-12-16 Ionic liquids based on imidazolium salts incorporating a nitrile functionality

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/087,749 Expired - Fee Related US8101777B2 (en) 2003-08-26 2004-08-25 Ionic liquids based on imidazolium salts incorporating a nitrile functionality

Country Status (14)

Country Link
US (2) US8101777B2 (en)
EP (1) EP1660457B1 (en)
JP (1) JP4791361B2 (en)
KR (2) KR20110091827A (en)
CN (2) CN1839122B (en)
AT (1) ATE526314T1 (en)
AU (1) AU2004266847B2 (en)
BR (1) BRPI0414005A (en)
CA (1) CA2534864A1 (en)
ES (1) ES2374195T3 (en)
MX (1) MXPA06002214A (en)
PL (1) PL1660457T3 (en)
PT (1) PT1660457E (en)
WO (1) WO2005019185A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2373875T3 (en) 2002-03-05 2012-02-09 Transtech Pharma, Inc. DERIVATIVES OF AZOL MONO AND BICYCLES THAT INHIBIT THE INTERACTION OF LIGANDOS WITH RAGE.
JP4820535B2 (en) * 2004-02-24 2011-11-24 弘幸 大野 New imidazolium compounds
WO2006007703A1 (en) * 2004-07-16 2006-01-26 Simon Fraser University Phosphonium ionic liquids as recyclable solvents for solution phase chemistry
GB0500029D0 (en) 2005-01-04 2005-02-09 Univ Belfast Basic ionic liquids
WO2007038360A2 (en) * 2005-09-22 2007-04-05 E. I. Du Pont De Nemours And Company Preparation of polytrimethylene ether glycol and copolymers thereof
US7674608B2 (en) 2007-02-23 2010-03-09 The University Of Toledo Saccharifying cellulose
EP2137318A4 (en) 2007-03-14 2012-01-04 Univ Toledo Biomass pretreatment
FR2915406B1 (en) * 2007-04-26 2010-03-12 Inst Francais Du Petrole CATALYTIC COMPOSITION BASED ON NANOPARTICLES CONTAINING NITROGEN LIGAND IN IONIC LIQUID, PROCESS FOR PREPARING, METHOD FOR HYDROGENATION OF OLEFINIC CHARGE
JP5393066B2 (en) * 2008-06-26 2014-01-22 国立大学法人九州大学 Method for producing metal complex type ionic liquid, metal complex type ionic liquid, and method for producing metal nanoparticles using the same
US7999355B2 (en) * 2008-07-11 2011-08-16 Air Products And Chemicals, Inc. Aminosilanes for shallow trench isolation films
CA2772797C (en) 2009-09-30 2018-09-25 Transtech Pharma, Inc. Substituted imidazole derivatives
MD4233C1 (en) * 2012-03-02 2014-01-31 Институт Химии Академии Наук Молдовы Catalyst for the synthesis of 2-pyrrol-3-iloxindole derivatives
EP2995630A1 (en) 2014-09-09 2016-03-16 Dublin Institute of Technology Hybrid compounds formed from ionic liquids and uses thereof in ion selective electrodes
CN106632056A (en) * 2016-12-27 2017-05-10 济南大学 Preparation method of single crystal of alkynyl substituted imidazole ionic liquid
JP2023500501A (en) * 2019-11-07 2023-01-06 ディーエスエム アイピー アセッツ ビー．ブイ． Novel transition metal catalyst
EP4002505B1 (en) 2020-11-13 2023-11-01 Toyota Jidosha Kabushiki Kaisha Functionalized ionic liquids as stabilizers for perovskite solar cells
CN115160267B (en) * 2022-08-04 2024-01-16 安阳工学院 Ionic liquid type composite medium and method for preparing furfural compounds by adopting ionic liquid type composite medium
CN117327301B (en) * 2023-11-27 2024-02-13 江苏新视界先进功能纤维创新中心有限公司 Ionic liquid and preparation method and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8357E (en) 1906-12-14 1908-02-28 "Paris-Ignicole" Gas incandescent burner
FR8357M (en) * 1966-09-08 1971-02-08
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation
JP2000191916A (en) * 1998-12-28 2000-07-11 Toshiba Corp Electroconductive composition, photosensitive resist, antistatic agent and production of semiconductor device
CA2433346A1 (en) 2000-12-29 2002-07-11 John J. Egan Method for treating glaucoma ib
DE10105751B4 (en) * 2001-02-08 2005-09-29 Oxeno Olefinchemie Gmbh Process for the preparation of 1-octene
DE10145747A1 (en) 2001-09-17 2003-04-03 Solvent Innovation Gmbh Ionic liquids
DE10247578A1 (en) * 2002-10-13 2004-04-22 Solvent Innovation Gmbh Functionalized ionic liquids obtained by a new, more efficient and low-cost method, used as solvents in catalytic reactions or as extractants, entrainers, wash liquids, heat transfer media, surfactants, modifiers and plasticisers

Also Published As

Publication number Publication date
ATE526314T1 (en) 2011-10-15
AU2004266847B2 (en) 2008-08-07
WO2005019185A1 (en) 2005-03-03
CN1839122A (en) 2006-09-27
JP4791361B2 (en) 2011-10-12
KR20110091827A (en) 2011-08-12
US8101777B2 (en) 2012-01-24
PT1660457E (en) 2011-12-13
ES2374195T3 (en) 2012-02-14
KR20060069470A (en) 2006-06-21
AU2004266847A1 (en) 2005-03-03
CN1839122B (en) 2010-10-13
PL1660457T3 (en) 2012-05-31
MXPA06002214A (en) 2006-04-27
EP1660457A1 (en) 2006-05-31
CN101817785A (en) 2010-09-01
CA2534864A1 (en) 2005-03-03
BRPI0414005A (en) 2006-10-24
US20090143597A1 (en) 2009-06-04
JP2007503415A (en) 2007-02-22
EP1660457B1 (en) 2011-09-28

Similar Documents

Publication Publication Date Title
US20120108820A1 (en) Ionic liquids based on imidazolium salts incorporating a nitrile functionality
US9468919B2 (en) Ruthenium-diamine complexes and method for producing optically active compounds
Dyson Transition metal chemistry in ionic liquids
Dyson et al. A Comparison of Ruthenium‐Catalysed Arene Hydrogenation Reactions in Water and 1‐Alkyl‐3‐methylimidazolium Tetrafluoroborate Ionic Liquids
Govindaswamy et al. Mono and dinuclear rhodium, iridium and ruthenium complexes containing chelating 2, 2′-bipyrimidine ligands: Synthesis, molecular structure, electrochemistry and catalytic properties
US6509467B1 (en) Transfer hydrogenation process
EP1997555B1 (en) Immobilized lewis acid catalysts coated with ionic liquids and use thereof
US20050065020A1 (en) Ionic liquids containing secondary hydroxyl-groups and a method for their preparation
US8884044B2 (en) Ruthenium complexes having (P—P)—coordinated diphosphorus donor ligands and processes for preparing them
EP1210305B1 (en) Transfer hydrogenation process
EP2914606B1 (en) Complexes of phosphine ligands comprising a carba-closo-dodecaborate substituent
Dyson Biphasic chemistry utilising ionic liquids
Yang et al. Photocatalytic Reduction of CO2 in Ionic Liquid
Guerrand et al. Ionic liquids
Zhao Design, synthesis and applications of functionalized ionic liquids
Yue et al. Phosphonium Ionic Liquids
Feng et al. Pretreatment and Conversion of Shrimp/Crab Shells into High-Value Products with Ionic Liquids
Gautam et al. Palladium-Catalyzed Carbonylation Reactions in Ionic Liquids
Ji p K a in Ionic Liquids
Fellay Biphasic catalysis in aqueous and ionic liquid media
PL213062B1 (en) 4-benzyl-4-methylmorpholinear ionic liquids with a chiral organic anion and a method for production of 4-benzyl-4-methylmorpholinear ionic liquids with a chiral organic anion

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION